Annual Current Liabilities
$2.62 M
-$1.66 M-38.82%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual total current liabilities is $2.62 million, with the most recent change of -$1.66 million (-38.82%) on December 31, 2023.
- During the last 3 years, MTNB annual current liabilities has fallen by -$945.60 thousand (-26.51%).
- MTNB annual current liabilities is now -39.70% below its all-time high of $4.35 million, reached on December 31, 2021.
Performance
MTNB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.12 M
-$268.00 K-11.20%
September 30, 2024
Summary
- As of February 7, 2025, MTNB quarterly total current liabilities is $2.12 million, with the most recent change of -$268.00 thousand (-11.20%) on September 30, 2024.
- Over the past year, MTNB quarterly current liabilities has dropped by -$1.10 million (-34.22%).
- MTNB quarterly current liabilities is now -60.54% below its all-time high of $5.38 million, reached on June 30, 2022.
Performance
MTNB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MTNB Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.8% | -34.2% |
| 3 y3 years | -26.5% | -34.2% |
| 5 y5 years | -7.7% | -34.2% |
MTNB Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.7% | at low | -60.5% | +12.0% |
| 5 y | 5-year | -39.7% | at low | -60.5% | +12.0% |
| alltime | all time | -39.7% | +205.2% | -60.5% | +215.4% |
Matinas BioPharma Holdings Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.12 M(-11.2%) |
| Jun 2024 | - | $2.39 M(+19.7%) |
| Mar 2024 | - | $2.00 M(-23.8%) |
| Dec 2023 | $2.62 M(-38.8%) | $2.62 M(-18.8%) |
| Sep 2023 | - | $3.23 M(+24.7%) |
| Jun 2023 | - | $2.59 M(+36.6%) |
| Mar 2023 | - | $1.90 M(-55.8%) |
| Dec 2022 | $4.29 M(-1.4%) | $4.29 M(-12.6%) |
| Sep 2022 | - | $4.90 M(-8.9%) |
| Jun 2022 | - | $5.38 M(+42.8%) |
| Mar 2022 | - | $3.77 M(-13.3%) |
| Dec 2021 | $4.35 M(+21.9%) | $4.35 M(+6.1%) |
| Sep 2021 | - | $4.10 M(+14.1%) |
| Jun 2021 | - | $3.59 M(+61.7%) |
| Mar 2021 | - | $2.22 M(-37.7%) |
| Dec 2020 | $3.57 M(+15.2%) | $3.57 M(+25.7%) |
| Sep 2020 | - | $2.84 M(+17.9%) |
| Jun 2020 | - | $2.41 M(-5.3%) |
| Mar 2020 | - | $2.54 M(-17.9%) |
| Dec 2019 | $3.10 M | $3.10 M(+18.1%) |
| Sep 2019 | - | $2.62 M(-24.3%) |
| Jun 2019 | - | $3.46 M(+11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $3.12 M(+9.7%) |
| Dec 2018 | $2.84 M(+60.5%) | $2.84 M(+7.6%) |
| Sep 2018 | - | $2.64 M(+77.2%) |
| Jun 2018 | - | $1.49 M(+44.6%) |
| Mar 2018 | - | $1.03 M(-41.8%) |
| Dec 2017 | $1.77 M(+22.5%) | $1.77 M(-6.0%) |
| Sep 2017 | - | $1.88 M(+41.0%) |
| Jun 2017 | - | $1.34 M(-31.6%) |
| Mar 2017 | - | $1.95 M(+35.2%) |
| Dec 2016 | $1.44 M(+28.0%) | $1.44 M(+6.2%) |
| Sep 2016 | - | $1.36 M(+1.4%) |
| Jun 2016 | - | $1.34 M(+1.6%) |
| Mar 2016 | - | $1.32 M(+17.0%) |
| Dec 2015 | $1.13 M(+0.9%) | $1.13 M(+29.3%) |
| Sep 2015 | - | $872.80 K(-23.2%) |
| Jun 2015 | - | $1.14 M(-13.1%) |
| Mar 2015 | - | $1.31 M(+17.0%) |
| Dec 2014 | $1.12 M(+30.2%) | $1.12 M(+9.6%) |
| Sep 2014 | - | $1.02 M(+17.0%) |
| Jun 2014 | - | $872.20 K(+29.5%) |
| Mar 2014 | - | $673.40 K(-21.6%) |
| Dec 2013 | $859.00 K | $859.00 K |
FAQ
- What is Matinas BioPharma Holdings annual total current liabilities?
- What is the all time high annual current liabilities for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual current liabilities year-on-year change?
- What is Matinas BioPharma Holdings quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly current liabilities year-on-year change?
What is Matinas BioPharma Holdings annual total current liabilities?
The current annual current liabilities of MTNB is $2.62 M
What is the all time high annual current liabilities for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual total current liabilities is $4.35 M
What is Matinas BioPharma Holdings annual current liabilities year-on-year change?
Over the past year, MTNB annual total current liabilities has changed by -$1.66 M (-38.82%)
What is Matinas BioPharma Holdings quarterly total current liabilities?
The current quarterly current liabilities of MTNB is $2.12 M
What is the all time high quarterly current liabilities for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly total current liabilities is $5.38 M
What is Matinas BioPharma Holdings quarterly current liabilities year-on-year change?
Over the past year, MTNB quarterly total current liabilities has changed by -$1.10 M (-34.22%)